- December 5-9, 2025 | Atlanta - Zy Therapeutics will be attending AES 2025 in Atlanta, Georgia, where the team will highlight ongoing work toward developing a disease-modifying treatment for…
As Zy Therapeutics prepares for the 2025 American Epilepsy Society (AES) Annual Meeting, the company is placing a strong emphasis on building the strategic relationships needed to advance its rare-epilepsy…
Zy Therapeutics is gearing up for an important presence at the 2025 American Epilepsy Society (AES) Annual Meeting, where the company will highlight meaningful progress on Kamini® (ZY-001)—its lead investigational…
Zy Therapeutics will convene its 2025 Scientific Advisory Board (SAB) meeting during the American Epilepsy Society (AES) Annual Meeting on Friday, December 5, 2025, in Atlanta, Georgia. This Scientific Advisory…
- September 18–20, 2025 | Madison, WI - Zy Therapeutics is pleased to announce that our Chief Medical & Scientific Officer, Dr. Jeffrey Loeb, will be attending the Sturge-Weber Foundation…
Brain calcification is more than a radiographic finding, it’s a devastating driver of seizures, migraines, and cognitive decline in rare CNS diseases like Sturge-Weber Syndrome and Tuberous Sclerosis. At ZY…
- August 30 - September 3, 2025 | Lisbon, Potrugal - Zy Therapeutics is excited to announce that our CMO, Dr. Jeffrey Loeb, will be speaking at the XVIII Workshop…
- June 16-19 | Boston - Zy Therapeutics will be present at BIO 2025, one of the world’s leading biotechnology conventions, bringing together innovators, researchers, and industry partners from across…
- December 6-10, 2024 | Los Angeles, CA - Zy Therapeutics will be attending AES 2024 in Los Angeles to highlight its work toward developing a disease-modifying treatment for Sturge-Weber…
Zy Therapeutics is presenting new research findings at the American Society for Experimental Neurotherapeutics (ASENT) annual meeting, taking place in Bethesda, MD, from March 12–14, 2024. The team looks forward…